Skip to main content

Table 2 Differential expression levels of microRNAs associated with time to progression in patients with GBM

From: Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

microRNAs

Time To Progression(TTP)

< 9 months

> 9 months

p-value

< 12 months

> 12 months

p-value

< 15 months

> 15 months

p-value

hsa-miR-128b

7.56 ± 0.76

7.59 ± 0.74

0.6587

7.54 ± 0.75

7.67 ± 0.76

0.2028

7.53 ± 0.73

7.76 ± 0.81

0.0420

hsa-miR-323

6.19 ± 0.29

6.20 ± 0.28

0.5988

6.18 ± 0.29

6.22 ± 0.28

0.3012

6.18 ± 0.29

6.26 ± 0.30

0.0451

hsa-miR-329

6.06 ± 0.19

6.07 ± 0.21

0.6787

6.05 ± 0.20

6.07 ± 0.21

0.4293

6.05 ± 0.19

6.10 ± 0.22

0.0981

hsa-miR-106a

9.77 ± 0.77

9.95 ± 0.67

0.0439

9.77 ± 0.75

10.03 ± 0.67

0.0091

9.79 ± 0.73

10.03 ± 0.75

0.0305

hsa-miR-106b

10.69 ± 0.67

10.93 ± 0.58

0.0021

10.73 ± 0.67

10.91 ± 0.56

0.0398

10.75 ± 0.65

10.88 ± 0.60

0.1980

hsa-miR-21

14.22 ± 1.11

14.01 ± 1.04

0.1136

14.23 ± 1.07

13.86 ± 1.09

0.0089

14.23 ± 1.07

13.74 ± 1.08

0.0029

hsa-miR-92

10.15 ± 0.62

10.28 ± 0.64

0.0795

10.16 ± 0.62

10.32 ± 0.65

0.0497

10.16 ± 0.60

10.38 ± 0.71

0.0214

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us